Adaptive resistance to CARs in glioma – Nature.com
|
Adaptive resistance to CARs in glioma
Nature.com Glioblastoma (GBM) is one of the most common brain tumours and portends a poor prognosis; patient survival durations are typically <6 months for those with recurrent disease following surgery. Around 30% of newly diagnosed patients express the aberrant … |
